Clinical bottom line
Pain assessment and management in older adults with dementia remain challenging due to communication barriers and atypical pain presentations. Emerging evidence supports the use of validated observational tools tailored for cognitively impaired patients, such as PainChek®, to improve pain detection accuracy. Multimodal pain management strategies combining pharmacologic and non-pharmacologic interventions are recommended, with careful consideration of age-related pharmacodynamics and comorbidities. Despite advances, under-recognition and undertreatment of pain persist, underscoring the need for routine, systematic pain assessment integrated into clinical workflows to optimize patient comfort and functional outcomes (Schofield et al., 2015; Dunwoody et al., 2026).
What the evidence shows
Older adults with dementia often cannot reliably self-report pain, necessitating alternative assessment approaches. Observational pain assessment tools that evaluate facial expressions, vocalizations, and body movements have been developed and validated (Hadjistavropoulos et al., 2015; Malmstrom et al., 2010). The recent feasibility study by Dunwoody et al. (2026) demonstrated that PainChek®, a digital tool employing automated facial recognition and behavioral indicators, improved pain detection rates in hospitalized older adults with dementia compared to usual care. This suggests that technology-assisted assessment may enhance clinical sensitivity to pain in this population.
Pharmacologic management must balance efficacy with safety, given altered drug metabolism and increased sensitivity to adverse effects in older adults. Non-opioid analgesics remain first-line, with cautious use of opioids when indicated. Non-pharmacologic interventions, including physical therapy, massage, and environmental modifications, have demonstrated adjunctive benefits (Schofield et al., 2015; Hadjistavropoulos et al., 2015). Importantly, pain assessment itself can serve as an intervention by prompting timely treatment adjustments and improving patient comfort (Fuchs-Lacelle et al., 2008).
Barriers to optimal pain management include clinician under-recognition, limited training on dementia-specific pain assessment, and organizational constraints (Suwanraj et al., 2021). Addressing these barriers through education and workflow integration is critical for improving outcomes.
Caveats and uncertainty
Most evidence derives from observational studies, feasibility trials, and expert consensus rather than large randomized controlled trials specifically targeting pain management in dementia. The heterogeneity of dementia subtypes and stages complicates generalizability. While tools like PainChek® show promise, their implementation requires validation across diverse care settings and populations. Pharmacologic recommendations are often extrapolated from broader geriatric pain literature due to limited dementia-specific trials. Potential risks of polypharmacy and adverse drug events necessitate individualized treatment plans and close monitoring.
How this may change practice
Clinicians should incorporate validated observational pain assessment tools into routine care for older adults with dementia, particularly in acute and long-term care settings. Adoption of technology-assisted tools like PainChek® may enhance detection accuracy and facilitate timely intervention. Multimodal pain management protocols that integrate pharmacologic and non-pharmacologic strategies tailored to cognitive status and comorbidities should be prioritized. Education programs addressing dementia-specific pain recognition and management barriers can improve clinician confidence and patient outcomes. Ultimately, systematic pain assessment should be recognized as a critical component of comprehensive dementia care to reduce suffering and improve quality of life.